drugset
drugset / Trial / NCT03087786

Oral Mucosal Effects In Adult Smokers Associated With Two Nicotine Lozenge Formulations

NCT03087786 ↗

Phase 1 Completed 100 enrolled Niconovum USA Inflamax Research Incorporated · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

To study the oral mucosal effects in adult smokers associated with the use of two Nicotine Lozenge formulations.

Timeline

Start
2017-03-21
Primary completion
2017-08-13
Completion
2017-08-13

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nicotine Unknown 4 mg Oral

Indications

No indication recorded.